The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation
Open accessAbstract
ADP is an important platelet agonist causing shape change and aggregation required for physiological hemostasis. We recently demonstrated the existence of two distinct G protein-coupled ADP receptors on platelets, one coupled to phospholipase C, P2Y1, and the other to inhibition of adenylyl cyclase, P2T AC . In this study, using specific antagonists for these two receptors, we demonstrated that concomitant intracellular signaling from both the P2T AC and P2Y1 receptors is essential for ADP-induced platelet aggregation. Inhibition of signaling through either receptor, by specific antagonists, is sufficient to block ADP-induced platelet aggregation. Furthermore, signaling through the P2T AC receptor could be replaced by activation of α 2A -adrenergic receptors. On the other hand, activation of serotonin receptors supplements signaling through the P2Y1 receptor. Moreover, this mechanism of ADP-induced platelet aggregation could be mimicked by coactivation of two non-ADP receptors coupled to G i and G q , neither of which can cause platelet aggregation by itself. We propose that platelet aggregation results from concomitant signaling from both the G i and G q , a mechanism by which G protein-coupled receptors elicit a physiological response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., & Moolenaar, W. H. (1989) · Cell · doi:10.1016/0092-8674(89)90868-4 · Cited by 836
Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood Platelets
GAARDER, A., JONSEN, J., LALAND, S., HELLEM, A., & OWREN, P. A. (1961) · Nature · doi:10.1038/192531a0 · Cited by 786
Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger
Moolenaar, W. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12949 · Cited by 584
Defective platelet activation in Gαq-deficient mice
Offermanns, S., Toombs, C. F., Hu, Y.-H., & Simon, M. I. (1997) · Nature · doi:10.1038/38284 · Cited by 561
Molecular Basis for ADP-induced Platelet Activation
Jin, J., Daniel, J. L., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2030 · Cited by 477
Self-citationMolecular Basis for ADP-induced Platelet Activation
Daniel, J. L., Dangelmaier, C., Jin, J., Ashby, B., Smith, J. B., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2024 · Cited by 441
Self-citationTowards a revised nomenclature for P1 and P2 receptors
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Dubyak, G. R., Harden, T. K., Jacobson, K. A., Schwabe, U., & Williams, M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01038-3 · Cited by 347
Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase
Communi, D., Govaerts, C., Parmentier, M., & Boeynaems, J.-M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.31969 · Cited by 341
Hirata, T., Ushikubi, F., Kakizuka, A., Okuma, M., & Narumiya, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118518 · Cited by 301
Léon, C., Hechler, B., Vial, C., Leray, C., Cazenave, J.-P., & Gachet, C. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00022-7 · Cited by 296
Seuwen, K., Magnaldo, I., & Pouysségur, J. (1988) · Nature · doi:10.1038/335254a0 · Cited by 279
Hung, D. T., Wong, Y. H., Vu, T. K., & Coughlin, S. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36762-6 · Cited by 255
Identification of competitive antagonists of the P2Y1 receptor.
Boyer, J. L., Romero-Avila, T., Schachter, J. B., & Harden, T. K. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09561-6 · Cited by 246
Activation of Receptor-operated Cation Channels via P2X1 Not P2T Purinoceptors in Human Platelets
MacKenzie, A. B., Mahaut-Smith, M. P., & Sage, S. O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.2879 · Cited by 210
Role of P2Y1 purinoceptor in ADP‐induced platelet activation
Savi, P., Beauverger, P., Labouret, C., Delfaud, M., Salel, V, Kaghad, M., & Herbert, J. M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00025-8 · Cited by 197
Hirata, T., Kakizuka, A., Ushikubi, F., Fuse, I., Okuma, M., & Narumiya, S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117510 · Cited by 195
Macfarlane, D., & Mills, D. (1975) · Blood · doi:10.1182/blood.v46.3.309.309 · Cited by 180
Mills, D. C. B. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650674 · Cited by 163
Transmembrane Receptors and Intracellular Pathways that Control Cell Proliferation
Pouysségur, J., & Seuwen, K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.001211 · Cited by 154
Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia Cells
Akbar, G. K. M., Dasari, V. R., Webb, T. E., Ayyanathan, K., Pillarisetti, K., Sandhu, A. K., Athwal, R. S., Daniel, J. L., Ashby, B., Barnard, E. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18363 · Cited by 148
Self-citationEpinephrine potentiates human platelet activation but is not an aggregating agent
Lanza, F., Beretz, A., Stierlé, A., Hanau, D., Kubina, M., & Cazenave, J. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.255.6.h1276 · Cited by 137
Mediation of growth factor induced DNA synthesis and calcium mobilization by Gq and Gi2.
LaMorte, V. J., Harootunian, A. T., Am, S., Tsien, R. Y., & Feramisco, J. R. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.121.1.91 · Cited by 108
Gabbeta, J., Xu, Y., Kowalska, M. A., Sun, L., Dhanasekaran, N., & Rao, A. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8750 · Cited by 94
Cusack, N. J., & Hourani, S. M. O. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09210.x · Cited by 93
G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts.
Baffy, G., Yang, L., Raj, S. R., Manning, D. R., & WILLIAMSON, J. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37219-8 · Cited by 81
Steen, V. M., Holmsen, H., & Aarbakke, G. M. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649614 · Cited by 80
Cusack, N. J., & Hourani, S. M. O. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09302.x · Cited by 53
Multiple Signal-Transduction Pathways Synergize in Platelet Activation
Siess, W. (1991) · Physiology · doi:10.1152/physiologyonline.1991.6.2.51 · Cited by 30
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Abbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,281
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
Identification and Biological Activity of the Active Metabolite of Clopidogrel
Savi, P., Pereillo, J. M., Uzabiaga, M. F., Combalbert, J., Picard, C., Maffrand, J. P., Pascal, M., & Herbert, J. M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614133 · Cited by 754
Activation of Platelet Function Through G Protein–Coupled Receptors
Offermanns, S. (2006) · Circulation Research · doi:10.1161/01.res.0000251742.71301.16 · Cited by 725
Metadata
- Authors
- Jin, J., & Kunapuli, S. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-07-07
- Volume
- 95
- Issue
- 14
- Pages
- 8070-8074
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2016217548
- Cited by
- 540
- References
- 29
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.